2020
DOI: 10.1172/jci133194
|View full text |Cite
|
Sign up to set email alerts
|

Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
23
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 49 publications
(100 reference statements)
1
23
0
Order By: Relevance
“…We were not able to measure ventilation as part of the expedition. Whilst there is good reason to believe iron bioavailability might affect pulmonary ventilation via an action on the hypoxia inducible factor pathway within carotid body glomus cells [ 11 ], no human study has detected such a phenomenon [ 8 , 12 ]. Moreover, the expected direction of effect is for iron to diminish alveolar ventilation rather than augment it.…”
mentioning
confidence: 99%
“…We were not able to measure ventilation as part of the expedition. Whilst there is good reason to believe iron bioavailability might affect pulmonary ventilation via an action on the hypoxia inducible factor pathway within carotid body glomus cells [ 11 ], no human study has detected such a phenomenon [ 8 , 12 ]. Moreover, the expected direction of effect is for iron to diminish alveolar ventilation rather than augment it.…”
mentioning
confidence: 99%
“…A recent phase I trial of PT2385 in humans with previously treated, advanced CCRCC reported evidence of anti-tumour activity in 14% patients with a favourable safety profile, although the predictable side-effect of anaemia occurred in 45% patients [211]. Of interest, dyspnoea and hypoxaemia are also recognised side-effects and presumably relate to inhibition of HIF-2α signalling in the carotid body [212]. These drugs may also be effective in treating other tumours in which HIF-2α is implicated in tumorigenesis, including RCCs caused by mutations in FH, SDH, and TCEB1 and PGL/PCC [213,214].…”
Section: Therapeutic Targeting Of Tumour Hypoxia and The Hif Systemmentioning
confidence: 99%
“…It is well recognised that time-dependent augmentation of HVR and thus increased ventilation accompanies adaptation to altitude [113,150]. In this respect, a recent study has highlighted the role of carotid body activation and type I cell proliferative responses to sustained hypoxia during ventilatory acclimatisation, a process that is mediated by HIF-2α, and abrogated by its inhibition [151]. However, evidence suggests that ventilatory acclimatisation is, at least in part, also determined by adjustment of NTS afferent inputs to RVLM [152], where regulation of AMPK-α1 expression [107] and consequent adjustments to AMPK-dependent facilitation of HVR may come in to play [10,112].…”
Section: Regulation Of Oxygen Supply Feeding and Food Choice During mentioning
confidence: 99%